Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Torres

Showing results (391-400 of 794) with videos related to

Pageof 80
Sort By:
Critical Care (London, England)|September 16, 2015
Improvement of antibiotic therapy and ICU survival in severe non-pneumococcal community-acquired pneumonia: a matched case-control studySimone Gattarello, Leonel Lagunes, Loreto Vidaur, et al.
The European Respiratory Journal|May 21, 2020
Difficult to treat microorganisms in patients aged over 80 years with community-acquired pneumonia: the prevalence of PES pathogensCatia Cilloniz, Cristina Dominedo, Héctor José Peroni, et al.
Medicina Clinica|June 28, 2003
[Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit. A study of 20 cases]María Molina-Molina, Joan Ramon Badia, Alejandra Marín-Arguedas, et al.
The European Respiratory Journal|July 7, 2017
Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trialJacobo Sellares, Miquel Ferrer, Antonio Anton, et al.
Intensive Care Medicine|February 2, 2019
Challenges in severe community-acquired pneumonia: a point-of-view reviewAntoni Torres, James D Chalmers, Charles S Dela Cruz, et al.
Respiratory Research|October 2, 2017
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up studyRosario Menéndez, Raúl Méndez, Eva Polverino, et al.
Clinical Therapeutics|July 31, 2017
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive PathogensDavid B Huang, Thomas M File, Antoni Torres, et al.
ERJ Open Research|March 29, 2019
Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumoniaPouline M van Oort, Lieuwe D Bos, Pedro Póvoa, et al.
The European Respiratory Journal|April 23, 2016
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumoniaAdamantia Liapikou, Catia Cillóniz, Albert Gabarrús, et al.
The Lancet. Microbe|June 8, 2021
Combining immunomodulators and antivirals for COVID-19 - Authors' replyRaquel Almansa, Ana P Tedim, Amanda de la Fuente, et al.
Pageof 80

Showing results (391-400 of 794) with videos related to

Sort By:
Pageof 80
Critical Care (London, England)|September 16, 2015
Improvement of antibiotic therapy and ICU survival in severe non-pneumococcal community-acquired pneumonia: a matched case-control studySimone Gattarello, Leonel Lagunes, Loreto Vidaur, et al.
The European Respiratory Journal|May 21, 2020
Difficult to treat microorganisms in patients aged over 80 years with community-acquired pneumonia: the prevalence of PES pathogensCatia Cilloniz, Cristina Dominedo, Héctor José Peroni, et al.
Medicina Clinica|June 28, 2003
[Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit. A study of 20 cases]María Molina-Molina, Joan Ramon Badia, Alejandra Marín-Arguedas, et al.
The European Respiratory Journal|July 7, 2017
Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trialJacobo Sellares, Miquel Ferrer, Antonio Anton, et al.
Intensive Care Medicine|February 2, 2019
Challenges in severe community-acquired pneumonia: a point-of-view reviewAntoni Torres, James D Chalmers, Charles S Dela Cruz, et al.
Respiratory Research|October 2, 2017
Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up studyRosario Menéndez, Raúl Méndez, Eva Polverino, et al.
Clinical Therapeutics|July 31, 2017
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive PathogensDavid B Huang, Thomas M File, Antoni Torres, et al.
ERJ Open Research|March 29, 2019
Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumoniaPouline M van Oort, Lieuwe D Bos, Pedro Póvoa, et al.
The European Respiratory Journal|April 23, 2016
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumoniaAdamantia Liapikou, Catia Cillóniz, Albert Gabarrús, et al.
The Lancet. Microbe|June 8, 2021
Combining immunomodulators and antivirals for COVID-19 - Authors' replyRaquel Almansa, Ana P Tedim, Amanda de la Fuente, et al.
Pageof 80